Monograph
J01XC01 - Fusidic Acid |
Not porphyrinogenic |
NP |
Rationale
Hydrophilic steroid structure. May act as a CYP inducer on prolonged (> 2 weeks) use. Several references: safe/use
Chemical description
Antibacterial steroid used in staphylococcal infections. Excreted in bile after oxidative metabolism and glucuronidation. CYP-induction demonstrated not after 14 days, but after one month of therapy. French list: use. South African list: use. Australian list: safe. Peters:
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
United Kingdom
Denmark
Norway© NAPOS 2024